Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 7
Submit an article Journal homepage
109
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy

Guillaume Bertona Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, FranceView further author information
,
Robin Arcanib Internal Medicine and Therapeutics department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France;c Center for Cardiovascular and Nutrition research (C2VN), Aix-Marseille University, Marseille, FranceCorrespondence[email protected]
View further author information
,
Antoine Tichadoua Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, France;d TAGC, INSERM, UMR1090, Aix-Marseille University, Marseille, France;e SMARTc Unit, Pharmacokinetics Laboratory, Aix-Marseille University, Marseille, FranceView further author information
,
Laure Farnaulta Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, FranceView further author information
,
Pauline Rochea Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, FranceView further author information
,
Julien Collea Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, France;d TAGC, INSERM, UMR1090, Aix-Marseille University, Marseille, France;e SMARTc Unit, Pharmacokinetics Laboratory, Aix-Marseille University, Marseille, FranceView further author information
,
Vadim Ivanova Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, FranceView further author information
,
Cédric Merciera Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, FranceView further author information
,
Anne-Laure Coudercf Geriatric and Therapeutic Unit, Internal Medicine, CHU Sainte Marguerite, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, FranceView further author information
,
Regis Costelloa Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, France;d TAGC, INSERM, UMR1090, Aix-Marseille University, Marseille, France;e SMARTc Unit, Pharmacokinetics Laboratory, Aix-Marseille University, Marseille, FranceView further author information
,
David Taïebg Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, FranceView further author information
&
Geoffroy Ventona Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, France;d TAGC, INSERM, UMR1090, Aix-Marseille University, Marseille, France;e SMARTc Unit, Pharmacokinetics Laboratory, Aix-Marseille University, Marseille, FranceView further author information
 show all
Pages 1355-1357 | Received 18 Aug 2022, Accepted 01 Apr 2023, Published online: 12 Apr 2023

References

  • Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
  • Granfeldt Østgård LS, Medeiros BC, Sengeløv H, et al. Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study. J Clin Oncol. 2015;33(31):3641–3649.
  • Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125–135.
  • Goncalves I, Burbury K, Michael M, et al. Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series. Eur J Nucl Med Mol Imaging. 2019;46(9):1902–1910.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Ossenkoppele G, Montesinos P. Challenges in the diagnosis and treatment of secondary acute myeloid leukemia. Crit Rev Oncol Hematol. 2019;138:6–13.
  • Bodei L, Modlin IM, Luster M, et al. Myeloid neoplasms after chemotherapy and PRRT: myth and reality. Endocr Relat Cancer. 2016;23(8):C1–7.
  • Bergsma H, van Lom K, Raaijmakers MHGP, et al. Persistent hematologic dysfunction after peptide receptor radionuclide therapy with 177Lu-DOTATATE: incidence, course, and predicting factors in patients with gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2018;59(3):452–458.
  • Brieau B, Hentic O, Lebtahi R, et al. High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy. Endocr Relat Cancer. 2016;23(5):L17–23.
  • Lancet JE, Uy GL, Newell LF, et al. CPX-351 versus 7 + 3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol. 2021;8(7):e481–e491.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.